AzurRx BioPharma CEO Issues Letter to Shareholders

    NEXT STORY
    ARCA biopharma Announces FDA Approval of IND Application for AB201 as a Potential Treatment for COVID-19
    PREV STORY
    Arch Biopartners Receives Approval from Turkish Ministry of Health to Proceed with Phase II Trial for LSALT Peptide; Begins Screening Patients in Florida
    Subscribe to PM360
    Print Subscription
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    Progenics Pharmaceuticals to Present at the Cantor Fitzgerald 2017 Global Healthcare Conference

    NEW YORK, Sept. 20, 2017 (GLOBE NEWSWIRE) -- Progenics Pharmaceuticals, Inc. (Nasdaq:PGNX), an oncology ...

    author_avatar
    NASDAQ Market News

    Lee’s Pharmaceutical Announces First Patient Dosed With its Anti-PD-L1 Antibody Socazolimab, Licensed From Sorrento Therapeutics, as a First-Line Treatment of Extensive-Stage Small-Cell Lung Cancer

    author_avatar
    NASDAQ Market News

    RAPT Therapeutics Announces Late-Breaking Oral Presentation of Positive Results from Phase 1b Trial of RPT193 at the 30th European Academy of Dermatology and Venereology Congress

    author_avatar
    NASDAQ Market News